BeiGene Market Cap

BeiGene has a market cap or net worth of $25.20 billion as of May 13, 2025. Its market cap has increased by 62.36% in one year.

Market Cap

25.20B

Enterprise Value

23.68B

Revenue

4.18B

Ranking

n/a

PE Ratio

n/a

Stock Price

$15.95

Market Cap Chart

Since February 3, 2016, BeiGene's market cap has increased from 858.74M to 25.20B, an increase of 2,834.99%. That is a compound annual growth rate of 43.95%.

Market Cap History

Date	Market Cap	% Change
May 12, 2025	25.20B	28.15%
Dec 31, 2024	19.67B	4.69%
Dec 29, 2023	18.79B	-17.76%
Dec 30, 2022	22.84B	-17.96%
Dec 31, 2021	27.84B	18.51%
Dec 31, 2020	23.49B	131.83%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.64B
Nika Pharmaceuticals	1.02B
Veradigm	729.62M
Tian'an Technology Group	568.98M
CytoDyn	497.14M
Glass House Brands	478.11M
Elite Pharmaceuticals	468.54M
Northwest Biotherapeutics	395.18M

Market Cap Rankings